Assess the Efficacy of AZD8931 in Combination With Paclitaxel Versus Paclitaxel Alone in Patients With Gastric Cancer
Status:
Terminated
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to assess the efficacy and safety and PK of AZD8931 plus
paclitaxel versus paclitaxel alone in patients with metastatic, gastric or gastro-oesophageal
junction, cancer.